Exelon Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Rivastigmine Patch Compared to Melatonin Patch in Prevention of Postoperative Delirium
Condition:   Delirium Interventions:   Drug: Rivastigmine Transdermal System [Exelon];   Drug: Melatonin Sponsor:   Ain Shams University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2019 Category: Research Source Type: clinical trials

16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Condition:   Alzheimer's DiseaseIntervention:   Drug: RivastigmineSponsor:   Novartis PharmaceuticalsRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2013 Category: Research Source Type: clinical trials